Cargando…

Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review

BACKGROUND: Our goal is to review current literature regarding the role of multi-parametric magnetic resonance imaging (mpMRI) in the active surveillance (AS) of prostate cancer (PCa) and identify trends in rate of reclassification of risk category, performance of fusion biopsy (FB) versus systemati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellis, Elizabeth E., Frye, Thomas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Current Best Practice for Prostate Biopsy: What is the evidence?
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297445/ https://www.ncbi.nlm.nih.gov/pubmed/35872881 http://dx.doi.org/10.1177/17562872221106883

Ejemplares similares

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Integration of magnetic resonance imaging into prostate cancer nomograms
por: Brinkley, Garrett J., et al.
Publicado: (2022)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Schema and cancer detection rates for transperineal prostate biopsy templates: a review
por: Sidana, Abhinav, et al.
Publicado: (2022)

Multiparametric ultrasound of prostate: role in prostate cancer diagnosis
por: Kaneko, Masatomo, et al.
Publicado: (2022)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Role of molecular imaging in the detection of localized prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022)

A review of artificial intelligence in prostate cancer detection on imaging
por: Bhattacharya, Indrani, et al.
Publicado: (2022)

A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer
por: Greenberg, Jacob W., et al.
Publicado: (2022)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Kawasaki-like disease among Italian children in the COVID-19 era
por: Kuo, Ho-Chang
Publicado: (2020)

Severity predictors in pediatric SARS-CoV-2 and MIS-C
por: Zachariah, Philip
Publicado: (2021)

Maternal COVID-19 vaccine antibody response and passage into cord blood
por: Gray, Kathryn J.
Publicado: (2021)

Robust antibody response in children to acute COVID-19 infection and lasts for months
por: Zhao, Zhen, et al.
Publicado: (2022)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

Testing algorithm for identification of patients with TRK fusion cancer
por: Penault-Llorca, Frédérique, et al.
Publicado: (2019)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
por: Gavin, Dominic James, et al.
Publicado: (2020)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Stem cell therapy in retinal diseases?
por: Siqueira, Rubens Camargo
Publicado: (2012)

Autologous bone marrow transplantation in patients relapsed one year after R-CHOP?
por: Pereira, Juliana
Publicado: (2012)

Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
por: Aerts, Jan, et al.
Publicado: (2023)

Quantification of bleeding volume using computed tomography and clinical complications after percutaneous renal biopsy
por: Chikamatsu, Yoichiro, et al.
Publicado: (2017)

Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013
por: Zink, Corinna M, et al.
Publicado: (2019)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Accuracy of Prostate Magnetic Resonance Imaging: Reader Experience Matters
por: Kang, Hyunseon C., et al.
Publicado: (2021)

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
por: Olivier, Jonathan, et al.
Publicado: (2022)

Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohort
por: Navaratnarajah, Arunraj, et al.
Publicado: (2019)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Transperineal versus transrectal multi-parametric magnetic resonance imaging fusion targeted prostate biopsy
por: Rabah, Danny, et al.
Publicado: (2021)

Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging
por: Zhong, Allison Y., et al.
Publicado: (2022)

Updated UK Recommendations for HER2 assessment in breast cancer
por: Rakha, Emad A, et al.
Publicado: (2015)

Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted Biopsy
por: Bommelaere, Thomas, et al.
Publicado: (2022)

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0unqe6d2q3938c10n16sti018v